Original Articles: Asthma, Lower Airway DiseasesPerception of airflow obstruction in patients hospitalized for acute asthma
Section snippets
INTRODUCTION
Asthma is a chronic airway disorder characterized by variable airflow obstruction and respiratory symptoms, punctuated by periods of acute deterioration (acute asthma). Severe episodes of acute asthma result in approximately 475,000 hospitalizations per year in the United States.1 Patients with asthma may be unable to appreciate the severity of airflow obstruction (ie, have poor perception of airflow obstruction),2, 3, 4, 5 which may contribute to delays in seeking medical attention,6, 7
METHODS
This was a prospective cohort study of adults (≥18 years old) admitted with an attending physician diagnosis of acute asthma and airflow obstruction on spirometry to 1 of 2 inner-city academic medical centers from April 1, 2001, through October 31, 2002. Participants were excluded if they had a diagnosis of another chronic respiratory disorder, had a contraindication to inhaled corticosteroids or oral corticosteroids, were discharged to locations other than home, were previous participants,
RESULTS
There were 51 participants (78% of eligible patients agreed to participate) in this study (Table 1). Most were African American women who had been diagnosed as having asthma approximately 30 years ago. More than three-quarters had an ED visit, more than half had been hospitalized for asthma within the year before enrollment, and approximately two-thirds had at least 1 episode of near-fatal asthma. The median hospital length of stay was 3 days (interquartile range, 2-5 days). Forty-one (80%) of
DISCUSSION
In this high-risk, inner-city population of adults with asthma, perception of airflow obstruction was poor at both hospital discharge and a 2-week follow-up visit. There was also evidence of poor perception of change in airflow obstruction between the 2 visits. In addition, although asthma symptom control at each visit was not predictive of subsequent episodes of acute asthma within 90 days of discharge, more severe airflow obstruction at the follow-up visit and a smaller improvement in airflow
ACKNOWLEDGMENTS
We thank Jeffery T. Charbeneau, MS, for his assistance with statistical analyses and reviewing early drafts of the manuscript.
REFERENCES (31)
- et al.
Symptom perception in pediatric asthma: resistive loading and in vivo assessment compared
Chest
(2007) - et al.
Perception scoring of induced bronchoconstriction as an index of awareness of asthma symptoms
Chest
(1994) - et al.
Factors influencing patient decisions about the use of asthma controller medication
Ann Allergy Asthma Immunol
(2007) - et al.
The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea
Chest
(2002) - et al.
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
Respir Med
(2005) - et al.
Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception
Chest
(2006) - et al.
Assessing future need for acute care in adult asthmatics: the profile of asthma risk study: a prospective health maintenance organization-based study
Chest
(2007) - et al.
Are we closing the disparities gap? small-area analysis of asthma in Chicago
Chest
(2007) Trends in Asthma Morbidity and Mortality
(November 2007)- et al.
Effect of asthma severity on symptom perception in childhood asthma
Braz J Med Biol Res
(2002)
Understanding how asthmatics perceive symptom distress during a methacholine challenge
J Asthma
Chemosensitivity and perception of dyspnea in patients with a history of near-fatal asthma
N Engl J Med
Personality profiles and breathlessness perception in outpatients with different gradings of asthma
Am J Respir Crit Care Med
One-year experience with an inpatient asthma clinical pathway
Arch Pediatr Adolesc Med
Inpatient management of asthma in the Chicago suburbs: the Suburban Asthma Management Initiative (SAMI)
J Asthma
Cited by (19)
Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD): Measurement Properties of Novel Patient-Reported Symptom Measures
2022, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :Eradication of or a reduction in the frequency and severity of symptoms is an indicator of asthma control and a goal of asthma management.3,7,8 However, there is a poor correlation between objective measures of disease severity (eg, FEV1 and PEF) and patients’ self-reported experience of asthma symptoms.9-11 Asthma symptom severity can only be evaluated by the patients themselves and, as such, well-developed patient-reported outcome (PRO) measures are necessary for characterizing these experiences in clinical studies.
Assessing Asthma Symptoms in Adolescents and Adults: Qualitative Research Supporting Development of the Asthma Daily Symptom Diary
2016, Value in HealthCitation Excerpt :Among the goals of asthma management (as highlighted in clinical guidelines), and an indicator of overall asthma control, is the eradication of or reduction in asthma symptoms [7–9]. Nevertheless, there is a poor correlation between the aforementioned objective measures of disease severity and patients’ experience of asthma symptoms [10–12]. To provide a holistic understanding of patient disease severity and asthma control in clinical research, there is a need for standardized ways of assessing patients’ experience of asthma symptoms.
Asthma outcomes: Symptoms
2012, Journal of Allergy and Clinical ImmunologyCitation Excerpt :In addition, many trials employ “homemade” instruments to assess symptoms (ie, newly derived endpoints, such as asthma-free days, based on alternative analysis of the data collected by the instruments) that have neither been formally validated as an outcome measure nor described in published manuscripts, raising questions about the value of such assessments and precluding comparisons across studies. There is also limited validation of instruments in diverse populations, which is problematic given differences in symptom perception and reporting across different patient subgroups.8-10 Furthermore, evidence of minimal clinically important difference in a change in symptoms in longitudinal studies is largely lacking.
Asthma symptom perception and obesity in children
2010, Biological PsychologyPerioperative Respiratory Monitoring in Congenital Heart Disease Patients
2023, Congenital Heart Disease in Pediatric and Adult Patients: Anesthetic and Perioperative Management, Second Edition
Disclosures: Authors have nothing to disclose.
Funding Sources: Dr Davis was supported at the time of analysis and manuscript preparation and Dr Stein is supported currently by National Institutes of Health Training Grant HL007605. At the time of data collection, Dr Krishnan was supported by National Institutes of Health grant HL67850.